Bio-oil fractions composition derived from bio-oil
US-2024381867-A1 · Nov 21, 2024 · US
US10287309B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10287309-B2 |
| Application number | US-201415036390-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 28, 2014 |
| Priority date | Nov 14, 2013 |
| Publication date | May 14, 2019 |
| Grant date | May 14, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a disaccharide intermediate and a synthesis method thereof, relates to the chemical pharmaceutical field, and more specifically relates to a method for preparing a disaccharide segment of a key intermediate for chemically synthesizing heparin and heparinoid compounds. Disclosed are a new disaccharide intermediate and three methods for synthesizing the disaccharide intermediate, that is, compounds of a formula (4) and glucopyranose protected by different anomeric carbon are made to react in the presence of an active agent, to obtain the disaccharide intermediate. According to the technical solutions of the present invention, synthetic raw materials are easy to obtain, have a mild reaction condition, and are suitable for industrialized production.
Opening claim text (preview).
The invention claimed is: 1. A process for preparing a compound of formula (2), comprising a step of glycosylation reaction between a compound of formula (3) and a compound of formula (4) in the presence of an active agent: wherein: R is an alkanoyl group or an aroyl group, and R in the same formula represents the same groups; and the active agent is selected from one or more of boron trifluoride-diethyl ether complex, trimethylsilyl triflate, triethylsilyl triflate, t-butyl dimethylsilyl triflate, and trifluoromethanesulfonic acid. 2. The process according to claim 1 , wherein the anomeric carbon of the compound of formula (3) has a stereo-configuration of α or β or a mixture thereof. 3. The process according to claim 1 , wherein the glycosylation reaction is carried out in the presence of a solvent. 4. The process according to claim 1 , wherein R is an acetyl group or a benzoyl group. 5. The process according to claim 1 , wherein R is benzoyl. 6. The process according to claim 3 , wherein the solvent is ethyl acetate, methyl acetate, N,N-dimethylformamide, ethyl ether, methyl t-butyl ether, tetrahydrofuran, 2-methyl tetrahydrofuran, dioxane, acetonitrile, nitromethane, dichloromethane, 1,2-dichloroethane, or toluene, or a mixture thereof. 7. The process according to claim 1 , wherein R is an acetyl group.
Anhydrosugars, e.g. epoxides · CPC title
Processes for the preparation of sugar derivatives · CPC title
having the esterifying carboxyl radicals attached to acyclic carbon atoms · CPC title
having the esterifying carboxyl radicals directly attached to carbocyclic rings · CPC title
Heterocyclic radicals containing only oxygen as ring hetero atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.